ALTRAPHARMA Invest ApS: Financial statements 2015
CVR: 34483884
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 843,480 and a net result of DKK 6,623 compared with DKK 223,261 the year before. That is a decrease of 39.6% compared with the year before. Equity in the 2015 report amounted to DKK 379,389. The solvency ratio was 38.6%.
- Gross Profit
- DKK 843,480
- Profit/Loss
- DKK 6,623
- Equity
- DKK 379,389
- Total Assets
- DKK 982,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 843 t. | 7 t. | 379 t. | - |
| 2014 | - | 1.4 mio. | 223 t. | 623 t. | - |
| 2013 | - | 1.4 mio. | 145 t. | 650 t. | - |
Official annual report
How creditworthy is ALTRAPHARMA Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ALTRAPHARMA Invest ApS has published its annual report for 2014. Gross profit came to DKK 1,396,358, and the net result was DKK 223,261.
About ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.